Van Hulzen Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$5.62K 545
2024
Q4
$5.62K Buy
+100
New +$6.22K ﹤0.01% 836
2015
Q4
Sell
-7,600
Closed -$137K 149
2015
Q3
$137K Sell
7,600
-4,200
-36% -$96.5K 0.09% 118
2015
Q2
$351K Sell
11,800
-1,100
-9% -$27.6K 0.19% 96
2015
Q1
$284K Sell
12,900
-600
-4% -$15.2K 0.17% 108
2014
Q4
$370K Buy
13,500
+400
+3% +$9.73K 0.26% 76
2014
Q3
$254K Buy
+13,100
New +$240K 0.26% 58

Other funds holding EXAS

Van Hulzen Asset Management's EXAS Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 100 shares — an estimated $5.62K sold.

Van Hulzen Asset Management first reported a position in EXAS in Q3 2014 and held it in 6 quarters. The position peaked at $370K in Q4 2014. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 100 Exact Sciences shares in Q1 2025, an estimated $5.62K.
  • Van Hulzen Asset Management first reported a position in Exact Sciences in Q3 2014 and held it in 6 quarters.
  • Van Hulzen Asset Management's Exact Sciences position peaked at $370K in Q4 2014.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.